The isolated country announced 21 new "fever" deaths on Saturday
coronavirus2 days ago
South Africa has changed its Covid-19 vaccination rules in an effort to encourage more people to get jabs, health authorities said on Monday.
Inoculations have slowed and the country — which has recorded more than 98,000 deaths and more than 3.6 million positive Covid-19 cases in total in the pandemic — has ample vaccine stocks.
The government is shortening the interval between the first and second doses of the Pfizer vaccine from 42 to 21 days and will allow people who have received two doses of Pfizer to get a booster dose three months after their second shot as opposed to six months previously.
ALSO READ:
It will also offer the option of “mixing and matching” booster jabs, with adults who were given one dose of Johnson & Johnson’s (J&J) vaccine being offered either a J&J or Pfizer booster two months after their J&J shot. Adults who received two doses of Pfizer will be allowed J&J as well as Pfizer as a third dose.
“The decision regarding which vaccine to administer as a booster should be guided by vaccine availability,” the health department said in a statement.
South Africa has recorded the most coronavirus infections and deaths on the African continent.
It has so far fully vaccinated 28 per cent of its roughly 60 million population, or 42 per cent of its 40 million adults. That is a far greater percentage than many other African countries but well short of government targets.
Its vaccination campaign, using the J&J and Pfizer vaccines, got off to a slow start due to difficulties securing early supplies but more recently it has been dogged by hesitancy.
Also on Monday, a government adviser on Covid-19 treatments shed further light on a recommendation that the state should not buy Merck & Co’s pill molnupiravir for now, despite the health regulator authorising its use.
Jeremy Nel, head of the infectious diseases division at the University of the Witwatersrand, told Reuters that the National Essential Medicines List Committee had given molnupiravir a “conditional no” on the basis that the cost would be substantial and benefits relatively small.
“It’s not a magic bullet that is going to solve Covid,” Nel said of molnupiravir.
Pfizer’s treatment pill Paxlovid was going to become available and had shown greater efficacy, Nel said. The committee is reviewing evidence on Paxlovid and should come up with a recommendation for government within weeks.
South Africa’s decision to steer away from buying molnupiravir comes after France cancelled its order following disappointing trial data. France hopes to get Paxlovid instead.
The isolated country announced 21 new "fever" deaths on Saturday
coronavirus2 days ago
The total doses administered now stand at 24.8 million
coronavirus2 days ago
Over 158.6 million PCR tests have been conducted in the country so far
coronavirus2 days ago
Ardern will be required to isolate until the morning of May 21, undertaking what duties she can remotely
coronavirus2 days ago
Nearly 300,000 people remain in quarantine due to a rapid spread of fever
coronavirus2 days ago
The contribution will go towards facilitating easy access of testing kits and specialised medical supplies
coronavirus2 days ago
Over 158.4 million PCR tests have been conducted in the country so far
coronavirus3 days ago
350,000 others have been treated for a fever that has spread 'explosively'
coronavirus3 days ago